dsp 4 has been researched along with Ataxia in 2 studies
DSP 4: RN given refers to parent cpd
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatip-Al-Khatib, I | 1 |
| Bolukbasi, F | 1 |
| Harkin, A | 1 |
| Morris, K | 1 |
| Kelly, JP | 1 |
| O'Donnell, JM | 1 |
| Leonard, BE | 1 |
2 other studies available for dsp 4 and Ataxia
| Article | Year |
|---|---|
Destruction of the noradrenergic system with DSP4 potentiates the behavioral effects of MK-801 in rats.
Topics: Adrenergic Agents; Animals; Ataxia; Behavior, Animal; Benzylamines; Dizocilpine Maleate; Drug Synerg | 1999 |
Modulation of MK-801-induced behaviour by noradrenergic agents in mice.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibi | 2001 |